| Literature DB >> 33238506 |
André Hajek1, Benedikt Kretzler1, Hans-Helmut König1.
Abstract
No systematic review has appeared so far synthesizing the evidence regarding multimorbidity and loneliness, social isolation, or social frailty. Consequently, our aim was to fill this gap. Three electronic databases (PubMed, PsycINFO, and CINAHL) were searched in our study. Observational studies examining the link between multimorbidity and loneliness, social isolation, and social frailty were included, whereas disease-specific samples were excluded. Data extraction included methods, characteristics of the sample, and the main results. A quality assessment was conducted. Two reviewers performed the study selection, data extraction, and quality assessment. In sum, eight studies were included in the final synthesis. Some cross-sectional and longitudinal studies point to an association between multimorbidity and increased levels of loneliness. However, the associations between multimorbidity and social isolation as well as social frailty remain largely underexplored. The quality of the studies included was rather high. In conclusion, most of the included studies showed a link between multimorbidity and increased loneliness. However, there is a lack of studies examining the association between multimorbidity and social isolation as well as social frailty. Future studies are required to shed light on these important associations. This is particularly important in times of the COVID-19 pandemic.Entities:
Keywords: COVID-19; SARS-CoV-2; chronic diseases; loneliness; multimorbidity; multiple chronic conditions; social exclusion; social frailty; social isolation
Mesh:
Year: 2020 PMID: 33238506 PMCID: PMC7700324 DOI: 10.3390/ijerph17228688
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Search strategy (PubMed).
| # | Search Term |
|---|---|
| #1 | Loneliness |
| #2 | Social exclusion |
| #3 | Social frailty |
| #4 | Social isolation |
| #5 | #1 OR #2 OR #3 OR #4 |
| #6 | Multimorbidity |
| #7 | multiple chronic |
| #8 | disease * |
| #9 | condition * |
| #10 | illness * |
| #11 | #7 AND (#8 OR #9 OR #10) |
| #12 | #6 OR #11 |
| #13 | #5 AND #12 |
Notes: Please note that the asterisk (“*”: in “disease*” (#8)) in PubMed is a truncation symbol. It can be used at the end of a word to search for all terms that begin with that basic root.
Figure 1Flow chart.
Extracted data.
| Study | Study Type/Time Span | Sample Source/Size | Age | Loneliness Assessment | Multimorbidity Assessment | Main Results | Quality Assessment Score |
|---|---|---|---|---|---|---|---|
| Barlow, M et al. (2014) | Longitudinal | Montreal Aging and Health Study (Canada) | M = 71.2 | Two items | Number of chronic illnesses (from a list of 17 diseases) | Growth-curve models showed that chronic illness was positively associated with loneliness (yearly change: ß = 0.125, | Fair |
| Jessen, M et al. (2018) | Cross-sectional | National Longitudinal Survey of Ageing (Denmark) | Not reported | UCLA Loneliness scale (20 items) | Two or more chronic conditions (from a list of eight diseases) | Logistic regression revealed that loneliness was positively associated with multimorbidity (OR = 1.77, 95% CI: 1.20–3.35). | Good |
| Kristensen, K. et al. (2019a) | Longitudinal | German Aging Survey | M = 63.5 | De Jong Gierveld short scales for loneliness (six items) | Two or more illnesses (from a list of 13 diseases) | Fixed effects regression stated that multimorbidity was associated with increased levels of loneliness (ß = 0.06, | Good |
| Kristensen, K. et al. (2019b) | Cross-sectional | German Aging Survey | M = 59.8 | De Jong Gierveld short scales for loneliness (six items) | Two or more illnesses (from a list of 13 diseases) | Linear regression detected a positive association between multimorbidity and loneliness (ß = 0.08, | Good |
| Olaya, B. et al. (2017) | Longitudinal | Edad con Salud | M = 71.8 | UCLA Loneliness scale (three items) | Number of chronic conditions (from a list of eight diseases) | Cox Proportional Hazard models did not find an association between multimorbidity on the one side and high loneliness (ref.: low loneliness) (ß = 0.003, | Good |
| Renne, I & Gobbens, R. (2018) | Recruited from a general practice (The Netherlands) | M = 76.5 | Assessment of social domain of frailty (TFI (three items)) | Number of chronic conditions (from a list of nine diseases) | Linear regression showed that multimorbidity was negatively associated with quality of life (ß = -3.786, | Fair | |
| Singer, L. et al. (2019) | Longitudinal | English Longitudinal Study of Ageing | M = 66.0 | One item | Basic multimorbidity: two or more morbidities (from a list of 25 diseases) | Generalized Estimating Equations revealed that multimorbidity was positively associated with low household wealth (ref.: high) (OR = 1.47, 95% CI: 1.34–1.61), a low subjective social status (ref.: high) (OR = 1.14, 95% CI: 1.04–1.24), a semi/routine occupation (ref.: manager, professional) (OR = 1.07, 95% CI: 1.04–1.24), a low sense of control (ref.: high) (OR = 1.57, 95% CI: 1.41–1.74), having no friends (ref.: very/some supportive friends) (OR = 1.14, 95% CI: 1.02–1.26), having no partner (ref. very/some supportive partner) (OR = 1.15, 95% CI: 1.06–1.26) and loneliness (OR = 1.19, 95% CI: 1.11–1.28). | Fair |
| Wister, A. et al. (2016) | Cross-sectional | Canadian Community Health Survey (Canada) and Household, Income and Labor Dynamics in Australia | 45–54: 38.1% | Hughes et al. 3-item loneliness scale | Number of chronic illnesses (from a list of eight diseases) | OLS regression showed that there was a significant positive association between multimorbidity and loneliness for all combinations of age group, gender and country, except Australian men which were older than 75 (ß = 0.02, 95% CI: −0.14–0.17). | Good |
Notes: M = mean; SD = standard deviation; OR = odds ratio; OLS = ordinary least squares; TFI = Tilburg Frailty Indicator; UCLA = University of California, Los Angeles; Barlow et al. (2014): adjusted for age, female, socio-economic status and partnership status, and health engagement strategies as well as health-related self-protection; Jessen et al. (2018): adjusted for sex, year of birth, marital status, cohabitation status, attachment to the labor market, and home ownership; Kristensen et al. (2019a): adjusted for age, BMI, depressive symptoms, monthly net equivalent income, physical activity, self-rated health, marital status, and employment status; Kristensen et al. (2019b): adjusted for sex, age, marital status, monthly net equivalent income, BMI, depressive symptoms, current smoking status, alcohol consumption and physical activity; Olaya et al. (2017): adjusted for social support, loneliness, smoking, age, years of education, marital status, alcohol consumption, and depression; Renne & Gobbens (2018): adjusted for sex, age, marital status, education, and 15 frailty components from the Tilburg Frailty Indicator; Singer et al. (2019): adjusted for participation, sense of control, supportive children, supportive friends, and supportive partner; Wister et al. (2016): adjusted for marital status, foreign-born status, and education level.
Quality assessment.
| Questions | Studies | |||||||
|---|---|---|---|---|---|---|---|---|
| Barlow (2014) | Jessen (2018) | Kristensen (2019a) | Kristensen (2019b) | Olaya (2017) | Renne (2018) | Singer (2019) | Wister (2016) | |
| 1. Was the research question or objective in this paper clearly stated? | yes | yes | yes | yes | yes | yes | yes | yes |
| 2. Was the study population clearly specified and defined? | yes | yes | yes | yes | yes | yes | yes | yes |
| 3. Was the participation rate of eligible persons at least 50%? | not reported | yes (73.5%) | no (27.1%–50.3%) | no (27.1%) | yes (69.9%) | no (47.5%) | not reported | not reported |
| 4. Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? | yes | yes | yes | yes | yes | yes | yes | yes |
| 5. Was a sample size justification, power description, or variance and effect estimates provided? | no | no | no | no | no | no | no | no |
| 6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured? (if not prospective should be answered as ‘no’, even is exposure predated outcome) | yes | no (cross-sectional) | no (simultaneously) | no (cross-sectional) | no (simultaneously) | no (cross-sectional) | no (simultaneously) | no (cross-sectional) |
| 7. Was the timeframe sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? | yes | no (cross-sectional) | yes | no (cross-sectional) | no | no (cross-sectional) | yes | no (cross-sectional) |
| 8. For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as continuous variable)? | dichotomous and continuous | dichotomous | dichotomous | dichotomous | dichotomous | continuous | dichotomous | continuous |
| 9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | yes | yes | yes | yes | yes | yes | yes | yes |
| 10. Was the exposure(s) assessed more than once over time? | no | no | yes | no | no | no | yes | no |
| 11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | yes | yes | yes | yes | yes | yes | yes | yes |
| 12. Was loss to follow-up after baseline 20% or less? | yes | not applicable | no | not applicable | not reported | not applicable | not reported | not applicable |
| 13. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)? | yes | yes | yes | yes | yes | yes | yes | yes |
| Overall quality judgement | fair | good | good | good | good | fair | fair | good |